103210-76-0

Upstream product

• 2426-87-1 3-methoxy-4-(phenylmethoxy)benzaldehyde 
• 711-79-5 1-hydroxy-2-acetonaphthone 

Downstream Products

• 103210-29-3 (2RS,3SR)-3-(4-benzyloxy-3-methoxy-phenyl)-2,3-dibromo-1-(1-hydroxy-[2]naphthyl)-propan-1-one 
• 103512-62-5 1-(1-benzoyloxy-[2]naphthyl)-3t-(4-benzyloxy-3-methoxy-phenyl)-propenone 
• 98166-66-6 2-(4-benzyloxy-3-methoxyphenyl)-4H-benzo[h]chromen-4-one 
• 1353223-97-8 3-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-benzo[h]chromen-4-one 
• 98166-68-8 2-(4-hydroxy-3-methoxyphenyl)-4H-benzo[h]chromen-4-one 
• 122335-89-1 2-(4-(benzyloxy)-3-methoxyphenyl)-3-hydroxy-4H-benzo[h]chromen-4-one 

Relevant academic research and scientific papers

POLYPHENOL ANALOGS TO TREAT ISCHEMIA

The present invention provides methods of use of polyphenol compounds for treating, preventing, mitigating and delaying ischemia or a condition where ischemia occurs. In one embodiment, the method comprises providing a polyphenol analog; and administering

NEUROPROTECTIVE POLYPHENOL ANALOGS

The present invention provides neuroprotective polyphenol compounds, which can be synthetic analogs of fisetin, baicalein or chlorogenic acid, that maintain neuroprotective, anti-inflammatory, glutathione promoting, and/or antioxidant properties. The neur

Chemical modification of the multitarget neuroprotective compound fisetin

Many factors are implicated in age-related central nervous system (CNS) disorders, making it unlikely that modulating only a single factor will provide effective treatment. Perhaps a better approach is to identify small molecules that have multiple biolog